Wednesday, June 10, 2026

Patent intelligence · WO

WO 2007104583

COMPRIMÉ SÉCABLE AVEC PRÉCISION

granted A61K/92072
Status granted
Years to expiry 1
Applicant portfolio 25
Patent details — WO 2007104583
Jurisdiction
WO
Status
granted
Grant date
Sep 20, 2007
Expiration
Sep 15, 2027
CPC classes
A61K/92072
View on Google Patents ↗

Quick answer

WO 2007104583 (COMPRIMÉ SÉCABLE AVEC PRÉCISION) is held by BERLIN CHEMIE AG [DE]. Status: granted. Granted Sep 20, 2007. Expires Sep 15, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K/92072

More from BERLIN CHEMIE AG [DE]

Related pharmaceutical patents in our USPTO index.

  1. WO 2024252263

    COMPOSITIONS SOLIDES DE DICHLORHYDRATE D'ÉLACESTRANT, LEURS PROCÉDÉS DE FABRICATION ET MÉTHODES DE TRAITEMENT LES UTILISANT

    BERLIN CHEMIE AG [DE] · Expires Dec 7, 2044

    granted
  2. WO 2024023766

    POLYTHÉRAPIE À BASE D'INHIBITEUR DE P13K

    BERLIN CHEMIE AG [DE] · Expires Jan 27, 2044

    granted
  3. CA 3259243

    POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE BCL-2

    RYVU THERAPEUTICS S A [PL] · Expires Jan 27, 2044

    granted
  4. CA 3259252

    POLYTHÉRAPIE ANTICANCÉREUSE COMPRENANT UN INHIBITEUR DE FLT3

    RYVU THERAPEUTICS S A [PL] · Expires Jan 27, 2044

    granted
  5. WO 2022029639

    FORMULATIONS PHARMACEUTIQUES AMÉLIORÉES COMPRENANT DES INHIBITEURS DE PI3K

    BERLIN CHEMIE AG [DE] · Expires Feb 5, 2042

    granted
  6. US 2021015826

    ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINED THERAPY

    BERLIN CHEMIE AG [DE] · Expires Jan 16, 2041

    granted
  7. US 2020040086

    PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY

    BERLIN CHEMIE AG [DE] · Expires Feb 1, 2040

    granted
  8. CA 3102476

    ASSOCIATIONS PHARMACEUTIQUES

    BERLIN CHEMIE AG [DE] · Expires Dec 14, 2039

    granted

Frequently asked questions

What is US patent 2007104583?

WO 2007104583 (COMPRIMÉ SÉCABLE AVEC PRÉCISION) is held by BERLIN CHEMIE AG [DE]. Status: granted. Granted Sep 20, 2007. Expires Sep 15, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.

Who owns WO 2007104583?

BERLIN CHEMIE AG [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does WO 2007104583 expire?

Our index shows an expiration date of Sep 15, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.